Pesquisas alternativas:
compr » comer (Expandir a Pesquisa)
nata » natl (Expandir a Pesquisa), nat (Expandir a Pesquisa), nada (Expandir a Pesquisa)
nail » natl (Expandir a Pesquisa), neil (Expandir a Pesquisa), nair (Expandir a Pesquisa)
care » case (Expandir a Pesquisa)
compr » comer (Expandir a Pesquisa)
nata » natl (Expandir a Pesquisa), nat (Expandir a Pesquisa), nada (Expandir a Pesquisa)
nail » natl (Expandir a Pesquisa), neil (Expandir a Pesquisa), nair (Expandir a Pesquisa)
care » case (Expandir a Pesquisa)
1
Por Salsman, John M., Yanez, Betina, Smith, Kristin N., Beaumont, Jennifer L., Snyder, Mallory A., Barnes, Khouri, Clayman, Marla L.
Publicado no J Natl Compr Canc Netw (2016)
“... types (60%–74% informed). There was a significant effect for patient gender (OR=3.57, CI: 1.33, 9.60, p...”Publicado no J Natl Compr Canc Netw (2016)
Obter o texto integral
Obter o texto integral
Artigo
2
Por Madsen, Lydia T., Kuban, Deborah A., Choi, Seungtaek, Davis, John W., Kim, Jeri, Lee, Andrew K., Domain, Delora, Levy, Larry, Pisters, Louis L., Pettaway, Curtis A., Ward, John F., Logothetis, Christopher, Hoffman, Karen E.
Publicado no J Natl Compr Canc Netw (2014)
“...PURPOSE: Clinical oncology trials are hampered by low accrual rates with less than 5% of adult...”Publicado no J Natl Compr Canc Netw (2014)
Obter o texto integral
Obter o texto integral
Artigo
3
Por Hoppe, Richard T., Advani, Ranjana H., Ai, Weiyun Z., Ambinder, Richard F., Aoun, Patricia, Bello, Celeste M., Benitez, Cecil M., Bierman, Philip J., Blum, Kristie A., Chen, Robert, Dabaja, Bouthaina, Forero, Andres, Gordon, Leo I., Hernandez-Ilizaliturri, Francisco J., Hochberg, Ephraim P., Huang, Jiayi, Johnston, Patrick B., Khan, Nadia, Maloney, David G., Mauch, Peter M., Metzger, Monika, Moore, Joseph O., Morgan, David, Moskowitz, Craig H., Mulroney, Carolyn, Poppe, Matthew, Rabinovitch, Rachel, Seropian, Stuart, Tsien, Christina, Winter, Jane N., Yahalom, Joachim, Burns, Jennifer L., Sundar, Hema
Publicado no J Natl Compr Canc Netw (2015)
“...-point scale), is the standard initial treatment for patients with newly diagnosed CHL. Brentuximab...”Publicado no J Natl Compr Canc Netw (2015)
Obter o texto integral
Obter o texto integral
Artigo
4
“..., opportunities and challenges -- 2. Nanotechnology in photoprotection -- 3. Nanotechnology in nail care -- 4...”
Obter o texto integral
Obter o texto integral
Livro